Ocular Therapeutix (OCUL) Return on Capital Employed [ROCE] (2014 - 2026)
Ocular Therapeutix (OCUL) posted Return on Capital Employed [ROCE] of -48.09% for Q2 2026, up 11.06 percentage points from -59.15% a year earlier but down 6.65 percentage points from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Ocular Therapeutix's Return on Capital Employed [ROCE] came in at -46.38%, up 8.39 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of -2.63 percentage points (FY2020 to FY2025).
- In prior years, Ocular Therapeutix's Return on Capital Employed [ROCE] was -54.77% in FY2024 (-5.08 pp), -49.69% in FY2023 (+4.29 pp), -53.99% in FY2022 (-16.29 pp) and -37.69% in FY2021 (+6.06 pp).
- Quarterly Return on Capital Employed [ROCE] has run from a low of -90.15% in Q2 2023 to a high of -22.98% in Q2 2024 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] increased in four of the last eight quarters, with an average year-over-year change of -4.01 percentage points.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2024, with a gain of 67.16 percentage points; the weakest was Q2 2023, with a drop of 41.31 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -41.44% (Q1 2026), -48.33% (Q4 2025) and -65.69% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 17.83% |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 17.92% |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 6.28% |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 19.32% |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 9.54% |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 16.66% |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | -5.97% |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 11.86% |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 20.76% |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | -48.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.09% |
| Mar 31, 2026 | -41.44% |
| Dec 31, 2025 | -48.33% |
| Sep 30, 2025 | -65.69% |
| Jun 30, 2025 | -59.15% |
| Mar 31, 2025 | -51.80% |
| Dec 31, 2024 | -39.69% |
| Sep 30, 2024 | -30.22% |
| Jun 30, 2024 | -22.98% |
| Mar 31, 2024 | -24.64% |
| Dec 31, 2023 | -47.81% |
| Sep 30, 2023 | -76.06% |
| Jun 30, 2023 | -90.15% |
| Mar 31, 2023 | -76.33% |
| Dec 31, 2022 | -64.19% |
| Sep 30, 2022 | -56.64% |
| Jun 30, 2022 | -48.84% |
| Mar 31, 2022 | -43.90% |
| Dec 31, 2021 | -42.19% |
| Sep 30, 2021 | -37.34% |
API Access
Ocular Therapeutix Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();